Navigation Links
Soil Treatment Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
Date:2/10/2013

Albany, New York (PRWEB) February 10, 2013

Soil treatment processes are used for improving the biological and physical content of the soil which is degrading due to growing industrialization. The pollution caused by industries are mixing in the soil content which makes the soil infertile and further impacts the growth of crops negatively.

Related Report : Biofuel Enzymes Market
http://www.transparencymarketresearch.com/biofuel-enzymes-market.html

The global volumes demand for soil treatment is expected to grow at a CAGR of over 10% from 2012 to 2018. In terms of revenues, soil treatment market was estimated to be worth over USD 17 billion in 2011 and is expected to exceed a market worth USD 28 billion by 2018, growing at a CAGR of over 8% from 2012 to 2018. The market is primarily driven by growing concerns regarding the depletion of arable land on a global scale, and the government support to improve crop production in order to cater to the growing demand for food grains by a growing population. However, the lack of awareness mainly in the underdeveloped countries is acting as one of the major factors inhibiting the growth of the market.

The global market is governed by developed economies of North America and Europe which accounts for most of the demand for soil treatment globally. The growing economies of China and India, however, are responsible for the growth of the Asia Pacific region as Asia Pacific is expected to be the fastest growing market for soil treatment over the forecasted period. The report segments the global market for soil treatment on the basis of the type of the product such as organic amendment, weed controller, pest controller and pH adjusters.

Some of the leading companies operating in the global market for soil treatment include Arkema S.A., Amvec C
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Hepatic function testing can assist in treatment planning for liver cancer patients
2. Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
3. Clot-Buster Drug May Still Be Best Stroke Treatment
4. Children with ACL injuries require special treatment
5. Research fellowships to advance medical treatments and bring new science to market
6. Physicians Group Calls on the FDA to Repurpose Enbrel for the Treatment of TBI, Stroke and Alzheimer’s Disease
7. Obesity treatment breakthrough described in EurekAlert!s No. 1 most-visited news release in 2012
8. 3 NIH-sponsored clinical trials test influenza treatments
9. World Stem Cells, LLC. facilitates Stem Cell Treatments In Cancun at World Stem Cells Clinic
10. Beware Fake Flu Treatments, FDA Warns
11. Fibroid Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... ... the upper extremity surgical market, announced today that more than 600 successful patient ... in the hand. Plus, nearly 70 of these procedures have been on ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... content, records and case management solutions and services to both government and commercial ... Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC ...
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, over 27,000 people ... the largest single-company convention to date for the state of Utah. , “We are ... tremendous event,” states David Stirling, doTERRA CEO. “One of the most exciting elements of ...
(Date:9/2/2015)... ... ... G-Hold ” was featured on NewsWatch as part of its monthly Tech Report, which ... expert and special reporter for NewsWatch, conducted the review and shared with viewers how ... likelihood of it dropping. , Tablets like the iPad and Samsung Galaxy Tab have ...
(Date:9/2/2015)... ... 02, 2015 , ... The payroll conference theme this year ... education covering legislative updates, including unemployment, global payroll best practices, and the latest ... Ultimate Software, the American Payroll Association, Barnett Associates, and the IRS, will keep ...
Breaking Medicine News(10 mins):Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:23rd Annual NJ Statewide Payroll Conference in Vernon, NJ at the Minerals Hotel on October 15-16, 2015 2
... women,s risk gets even smaller 10 years after stopping ... News) -- Women taking oral contraceptives are at a ... decade after stopping the pill even this very small ... that finding doesn,t change the recommendation for women to ...
... year over year growth driven by Loestrin 24 and Taclonex; Company ... updates full year 2007 financial guidance, ST. ... today announced its results for the quarter ended,September 30, 2007. Revenue ... of 16.3%, over the prior year quarter. The,primary drivers of the ...
... Highlighted by Continued Momentum in Global Commercialization, Program for Once-Daily ... ... III Study -, LAVAL, QC, Nov. 9 /PRNewswire-FirstCall/ - ... the third quarter of fiscal,2007, ended September 30, 2007. All ...
... event in 2007, net loss stable ... otherwise noted), BELLEVILLE, ON, Nov. 9 /PRNewswire-FirstCall/ - ... company, today announced financial results for the first,quarter of ... "We are also focused on the successful completion of ...
... Pharmaceutical product teams,have the power to make ... The problem is,launch teams often lack the right ... only produce a sub-optimal launch. In fact, ... and cross-functional team work are key ingredients,during product ...
... Support Continued Advancement of Novel Technology and ... ... Inc., a,privately-held therapeutic antibody product company, today announced that,it has raised ... A/S.,Additional investors participating significantly in the round were Frazier,Healthcare Ventures and ...
Cached Medicine News:Health News:Pill Poses Little Cervical Cancer Risk 2Health News:Pill Poses Little Cervical Cancer Risk 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 18Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 19Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 20Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 21Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 2Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 3Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 4Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 5Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 6Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 7Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 8Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 9Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 10Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 11Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 12Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 13Health News:Labopharm Reports Results for Third Quarter Fiscal 2007 14
(Date:9/2/2015)... YORK , Sept. 2, 2015 Relmada ... novel therapies for the treatment of chronic pain, announced ... meetings at both the FBR Second Annual Healthcare Conference ... as follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor ...
(Date:9/2/2015)... Tumultuous market conditions – including changes in ... activity – have led more than half of today,s ... reps. This marks the first time that the number ... point, according to the spring 2015 AccessMonitor™ report ... . AccessMonitor™ aggregates sales-call records ...
(Date:9/2/2015)... Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and ... development and commercialization of new cancer therapies, today ... "A Comparison of the Mechanisms and Cytotoxic ... Tumor Models Harboring Wild-type and Mutant p53," ...
Breaking Medicine Technology:Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4
... 2011 The Food and Drug Administration is urging ... marketed for infants to avoid giving the wrong dose ... of acetaminophen can cause serious side effects and, possibly, ... The agency is especially concerned about parents and caregivers ...
... EVANSTON, Ill., Dec. 22, 2011 AuraSense ... acid (SNA™) constructs as gene regulation- and ... applications in oncology, dermatology, neurology, and for ... financing.  Investors included Abbott Biotech Ventures, a ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - Know Concentration Before Giving Acetaminophen to Infants 2AuraSense Therapeutics Secures Series B Equity Investment 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: